CLAROMER Trademark

Trademark Overview

On Friday, March 26, 2021, a trademark application was filed for CLAROMER with the United States Patent and Trademark Office. The USPTO has given the CLAROMER trademark a serial number of 90604501. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, August 5, 2024. This trademark is owned by Maxwell Biosciences, Inc.. The CLAROMER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of viral, fungal or bacterial diseases or conditions
claromer

General Information

Serial Number90604501
Word MarkCLAROMER
Filing DateFriday, March 26, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, August 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of viral, fungal or bacterial diseases or conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMaxwell Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78738
Party NameMaxwell Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78738

Trademark Events

Event DateEvent Description
Tuesday, March 30, 2021NEW APPLICATION ENTERED
Thursday, July 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 4, 2021NON-FINAL ACTION E-MAILED
Thursday, November 4, 2021ASSIGNED TO EXAMINER
Thursday, November 4, 2021NON-FINAL ACTION WRITTEN
Thursday, November 4, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 8, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 8, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 8, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 8, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 9, 2023SOU EXTENSION 1 FILED
Thursday, February 9, 2023SOU EXTENSION 1 GRANTED
Saturday, February 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 7, 2023SOU EXTENSION 2 FILED
Monday, August 7, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 7, 2023SOU EXTENSION 2 GRANTED
Tuesday, December 19, 2023SOU EXTENSION 3 FILED
Tuesday, December 19, 2023SOU EXTENSION 3 GRANTED
Monday, August 5, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2024SOU EXTENSION 4 FILED
Monday, August 5, 2024SOU EXTENSION 4 GRANTED
Wednesday, August 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

claromer bacterial diseases conditions fungal viral preparations treatment prevention pharmaceutical